NCT03120624 2026-02-04VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial CancerMayo ClinicPhase 1 Active not recruiting34 enrolled 16 charts
NCT01822756 2018-02-12An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated42 enrolled 14 charts